Literature DB >> 25222224

Role of miR-149C>T polymorphisms on the risk of hepatocellular carcinoma in a Chinese population.

M F Liu1, W Q Chen1, Y Z He1, Y L Gu2.   

Abstract

MicroRNAs (miRNAs) are thought to play a role in cancer development. We conducted a case-control study to investigate the association between polymorphisms in miR-149C>T and hepatocellular carcinoma (HCC) risk. Duplex polymerase chain reaction with the confronting 2-pair primers were taken to genotype miR-149C>T. The association between genotype frequencies of miR-149C>T and risk of HCC was estimated as odds ratios (ORs) and 95% confidence intervals (95%CIs) using conditional regression analysis. Logistical regression analysis showed that the miR-149 CC genotype and C allele were associated with risk of HCC, with adjusted ORs (95%CI) of 2.07 (1.32-3.26) and 1.42 (1.06-2.12), respectively. Using the TT+TC genotype as a reference, individuals carrying the CC genotype were associated with non-significant increased risk of HCC, adjusted OR (95%CI) of 1.37 (0.91-2.07). Subgroup analysis showed that HBV-infected subjects carrying the miR-149 TC+CC genotype (OR=5.85, 95%CI=2.49-13.77) had an increased risk of HCC. In summary, our study found that miRNA-149C>T polymorphism is associated with risk of HCC, especially in HBV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25222224     DOI: 10.4238/2014.September.5.4

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  7 in total

1.  The miR-149 rs2292832 T/C polymorphism may decrease digestive cancer susceptibility: an updated meta-analysis.

Authors:  Lin Li; Tao Liu; Zuo Li; Lixin Zhang; Zhiqiang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Regulation and functions of MicroRNA-149 in human cancers.

Authors:  Yingru Zhi; Hao Zhou; Abudoureyimu Mubalake; Ying Chen; Bei Zhang; Kai Zhang; Xiaoyuan Chu; Rui Wang
Journal:  Cell Prolif       Date:  2018-07-12       Impact factor: 6.831

3.  Pre-miR-149 rs71428439 polymorphism is associated with increased cancer risk and AKT1/cyclinD1 signaling in hepatocellular carcinoma.

Authors:  Jiantao Wu; Shemin Lv; Jianbo An; Chunhui Lu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis.

Authors:  Ben-Gang Wang; Li-Yue Jiang; Qian Xu
Journal:  Biosci Rep       Date:  2018-09-25       Impact factor: 3.840

5.  Association of MiR-149 (RS2292832) Variant with the Risk of Coronary Artery Disease.

Authors:  Maryam Ghaffarzadeh; Hamid Ghaedi; Behnam Alipoor; Mir Davood Omrani; Faranak Kazerouni; Mehrnoosh Shanaki; Afsaneh Labbaf; Hossein Pashaiefar; Ali Rahimipour
Journal:  J Med Biochem       Date:  2017-07-14       Impact factor: 3.402

Review 6.  miR-149 in Human Cancer: A Systemic Review.

Authors:  Yunjie He; Dandan Yu; Lingping Zhu; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

Review 7.  MicroRNA-Related Polymorphisms in Infectious Diseases-Tiny Changes With a Huge Impact on Viral Infections and Potential Clinical Applications.

Authors:  Joel Henrique Ellwanger; Francis Maria Báo Zambra; Rafael Lima Guimarães; José Artur Bogo Chies
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.